Ubie
PrivateLast Round
Series C
Extension
Jun 26, 2025
Total Funding Raised
$248.4M
Company Overview
Ubie operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series C Extension round in June 2025.
Ubie is a health-tech company that develops an AI-powered platform to guide patients from symptoms to appropriate medical care and improve operational efficiency for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Patient Engagement, Vertical SaaS, Healthcare Analytics, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ubie Comparables
Compare Ubie with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fabric (US) | 81% | |
| Mediktor | 79% | |
| Infermedica | 79% |
For institutional investors. Book with your work email.
Ubie Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jun 26, 2025 | ||||
| Debt | May 8, 2025 | ||||
| Strategic | Oct 8, 2024 | ||||
| Corporate Funding | Apr 12, 2024 | ||||
| Debt | Apr 12, 2024 | ||||
Debt | Dec 8, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ubie Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Post Capital | Strategic |
| Sumitomo Mitsui Trust Bank | Debt, Corporate Funding |
| Shinsei Capital Partners | Series C |
| 株式会社日本政策金融公庫 | Debt, Strategic, Series C Extension |
| D4V (Design for Ventures) | Seed, Series A |
| MUFG Bank | Debt |
| Rakuten Capital | Series C Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Launched a new LLM-based chat platform for patient health guidance.
- Feb 12, 2026
Developing AI platform with Mayo Clinic for patient navigation.
For institutional investors. Book with your work email.
Ubie Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ubie's valuation, stock price, and market status.
Is Ubie a public or private company?
Ubie is a private company.
What is the current stock price of Ubie?
Ubie is a private company, so its shares have no public market price. Caplight tracks Ubie's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ubie worth (valuation)?
Valuation information for Ubie is not publicly available.
Can I buy Ubie stock?
Ubie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ubie's last funding round?
Ubie's most recent funding round was Series C Extension on June 26, 2025.
Who are the main investors in Ubie?
Key investors in Ubie include Japan Post Capital, Sumitomo Mitsui Trust Bank, Shinsei Capital Partners, 株式会社日本政策金融公庫, D4V (Design for Ventures).
Will Ubie IPO soon?
No public IPO plans have been announced for Ubie.
How can I track Ubie secondary market activity?
Caplight tracks bids, offers, and trades in Ubie's shares on secondary markets.